Vasculitis & polymyalgia rheumatica

Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study

Rheumatology (Oxford)Published Retrospective cohort study

Main finding · Severe infectionResult — go to the resultConfounder-adjusted HR 1.75 95% CI 1.03–3.00

Authors' conclusion

Regardless of treatment regimens, low IgG after remission-induction treatment was associated with the development of severe infections up to 48 weeks after treatment initiation.

Study context

Population
Patients with new-onset or severe relapsing antibody-associated vasculitis (AAV) in the J-CANVAS registry, 24 referral sites in JapanIgG measured in 510
Participants
657 patients
Exposure
Low IgG vs higher IgG during remission-induction therapy
  • Low IgGn = 77
Outcome
Severe infection
Follow-up
Up to 48 weeks after treatment initiation
Methodological detailsmulticentre (24 referral sites, J-CANVAS registry), multiple imputation, Fine-Gray model, restricted cubic spline
  • Multicentre (24 referral sites, J-CANVAS registry)
  • Multiple imputation
  • Fine-Gray model
  • Restricted cubic spline

Main finding

As reported in the abstract

up to 48 weeks

Confounder-adjusted HR

1.75

95% CI 1.03–3.00

Low IgGvs IgG ≥500 mg/dl
confounder-adjusted HR 1.75 (95% CI 1.03–3.00)

Observational data: associations, not effects.

Further findings

Severe infection, whole cohort · up to 48 weeks

Patients developing severe infections
111 (16.9%)

Low IgG prevalence among patients with IgG measured · up to 24 weeks

Low IgG
77 (15.1%)

Serum IgG and severe infection (restricted cubic spline (RCS))

U-shaped association; lowest point at serum IgG (mg/dl)
946

Treatment-regimen subgroups

No obvious heterogeneity between treatment regimens

Original publication

Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study. Rheumatology (Oxford). Published 24 March 2023. doi:10.1093/rheumatology/kead138

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.